Connect with us

Hi, what are you looking for?

Metaverse CapitalistsMetaverse Capitalists

Investing

New York City’s Two Overdose Prevention Centers Saved One Thousand Lives Since They Opened. Will The Feds Reward Them by Shutting Them Down?

Jeffrey A. Singer

OnPoint NYC, the harm reduction organization tasked with opening and operating New York City’s two overdose prevention centers (OPCs), announced that since the two centers (one in East Harlem and one in Washington Heights) launched on November 30, 2021, they had averted 1,008 overdoses. As of July 2023, more than 3,700 registered participants have used the centers nearly 84,000 times.

Unfortunately, the New York Times reports that Damian Williams, U.S. Attorney for Manhattan, responded to the news by implying he will take steps to close down the OPCs:

“I have repeatedly said that the opioid epidemic is a law enforcement crisis and a public health crisis,” Damian Williams, the U.S. attorney for the Southern District of New York, said in a statement to The New York Times. “But I am an enforcer, not a policymaker.” Until New York policymakers take action to authorize the supervised consumption sites, he said, they are operating in violation of federal, state and local law.

“That is unacceptable,” he added. “My office is prepared to exercise all options — including enforcement — if this situation does not change in short order.”

This is an ominous development. At a Cato online policy forum last March, Kailin See, the Senior Director of Programs for OnPoint NYC, told participants that the U.S. Department of Justice had sent inspectors to the two OPCs, who seemed pleasantly surprised at how they worked in the community. The Department of Justice has yet to act against the OPCs.

As I wrote in this Cato policy brief, OPCs have been around since the mid‐​1980s. There are now 147 government‐​sanctioned OPCs in 91 locations and 16 countries—including 38 in Canada, 14 in Switzerland (where the first OPC was opened in Bern in 1986), and 25 in Germany—preventing overdose deaths and the spread of HIV, hepatitis, and other diseases. But in this country, 21 U.S.C. Section 856, also known as the “crack house” statute, passed in the mid‐​80s, makes it illegal for entities to permit people to use prohibited drugs on their premises.

New York City’s mayor defied federal law by authorizing OnPoint NYC to open the OPCs amid soaring overdose deaths during the winter of 2021. The National Institutes of Health announced in May that it will fund a study to assess the effect the OPCs have had on drug use, overdoses, and diseases.

And Rhode Island and Minnesota lawmakers have recently authorized OPCs in their states.

But as the saying goes, “No good deed goes unpunished.” All this harm reduction progress can grind to a halt if the Justice Department decides to snuff out the OPCs.

In my policy brief, I called on Congress to repeal the “crack house” statute or “at an absolute minimum amend existing federal law so harm‐​reduction organizations can establish and run OPCs.” Until Congress acts, no harm reduction organization seeking to save lives in its community can ever feel safe from law enforcement’s wrath.

    You May Also Like

    Stocks

    In this edition of StockCharts TV‘s The Final Bar, Dave shows how breadth conditions have evolved so far in August, highlights the renewed strength in the...

    Business

    In the UK, the care sector is under incredible strain, it’s good to know there are people working hard to address the issue. One...

    Politics

    On January 10, the French government announced plans to raise the retirement age from 62 to 64. The change would mean that after 2027,...

    Business

    With the increased threat of industrial strike action looming across the UK, we consider whether a force majeure clause can strike the right chord...

    Dislaimer: pinnacleofinvestment.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 metaversecapitalists.com | All Rights Reserved